Chiron Inc., GalaGen deal

GalaGen (Arden Hills, Minn.) licensed from CHIR's Biocine Co. business unit CHIR's MF-59 adjuvant for use in producing Sporidin-G, GalaGen's orally delivered bovine antibody preparation that targets Cryptosporidium parvum. Sporidin-G is in a Phase I/II trial against the opportunistic parasite, which causes chronic diarrhea in AIDS patients. ...